OCTALFA

What is OCTALFA?

OCTALFA is a family-run investment entity focused on innovation, healthcare, and life sciences. They create, fund, and manage young innovative companies, with an emphasis on sectors such as biotechnology, pediatric medicine, cancer immunology, diagnostics, and materials.

Founded in 2006 and headquartered in Ecully, France, OCTALFA combines entrepreneurial ventures with a strong commitment to philanthropy, having integrated charitable actions into their business model since 2008. Through their subsidiaries and stakes, they are significantly involved in supporting individuals affected by cancer or disabilities, notably children, both in France and Madagascar.

Their engagement is articulated through their Corporate Foundation and Endowment Fund, which are essential parts of OCTALFA's strategy and governance. Through these entities, they support associative projects with strong social and economic potential for sustainable and shared development, reflecting their values of entrepreneurship and corporate social responsibility. To date, OCTALFA has financed or established 14 companies, invested over 22 million euros, generated more than 200 jobs, and led to the development of several innovative medications with international reach.

Additionally, the investment has resulted in over 200 supported associative projects, 2.2 million euros in donations, and benefited over 30,000 individuals in France and Madagascar.

Specifically, their subsidiary OREGA Biotech focuses on identifying therapeutic targets and tools to improve responses to anticancer immunotherapies, while ORPHELIA Pharma provides essential drugs in neurology and oncology with pediatric-appropriate formulations, underscoring OCTALFA's multifaceted expertise across various healthcare segments.